This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
| 238 | Mon, 8/2/2010, 2:00 PM - 3:50 PM | CC-302/303 (West) |
| Biomarkers — Contributed Papers | ||
| Biopharmaceutical Section | ||
| Chair(s): Neal Thomas, Pfizer Inc. | ||
| 2:05 PM | Evaluating Correlation and Some Misuses for Biomarker Qualification Within a Causal Correlation Framework — Yue Wang, Merck & Co., Inc. ; Robin Mogg, Merck & Co., Inc. ; Peter H. Hu, Merck & Co., Inc. ; Jared Lunceford, Merck & Co., Inc. ; Peggy Wong, Merck Research Laboratories | |
| 2:20 PM | Detecting a Cutoff Point for Predictive Biomarkers in Clinical Trials Using Contrast Tests — Jianliang Zhang, MedImmune | |
| 2:35 PM | Using Logistic Model with Measurement Errors in Covariates to Assess Baseline Biomarkers Association with Treatment Response — Dion Chen, Centocor R&D, Inc. ; Jiandong Lu, Johnson & Johnson | |
| 2:50 PM | An Orthogonal Transformed Aggregation Statistic to Test Gene Regulation with Prespecified Gene Sets or Pathways — Shuyan (Sabrina) Wan, Merck Research Laboratories ; Nanshi Sha, Columbia University ; Peggy Wong, Merck Research Laboratories | |
| 3:05 PM | Use of Receiver Operating Characteristic (ROC) Curves to Evaluate High-Throughput Screening (HTS) Methodologies — Satya R. Siddani, Merck & Co., Inc. | |
| 3:20 PM | Issues on Threshold Selection in Predictive Biomarker Analysis — Li-an Xu, Bristol-Myers Squibb | |
| 3:35 PM | Dimension Reduction Through Variable Selection: A Fibrosis Case Study — Katja Sabine Remlinger, GlaxoSmithKline | |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.